C4 Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.25
|
|
Average Rating
|
3.69
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
4
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.67
|
-0.65
|
0.02
|
2.99%
|
|
2022-06-30
|
-0.69
|
-0.56
|
0.13
|
18.84%
|
|
2022-03-31
|
-0.58
|
-0.65
|
-0.07
|
-12.07%
|
|
2021-12-31
|
-0.58
|
-0.31
|
0.27
|
46.55%
|
|
2021-09-30
|
-0.59
|
-0.51
|
0.08
|
13.56%
|
|
2021-06-30
|
-0.59
|
-0.51
|
0.08
|
13.56%
|
|
2021-03-31
|
-0.63
|
-0.49
|
0.14
|
22.22%
|
|
2020-12-31
|
-0.53
|
-0.04
|
0.49
|
92.45%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.86
|
|
2021-12-31
|
-1.82
|
|
2020-12-31
|
-17.69
|